Cart
sales@molnova.com
Glycochenodeoxycholic acid sodium salt
CAS No. 16564-43-5
Glycochenodeoxycholic acid sodium salt( GCDCA | Sodium glycochenodeoxycholate )
Catalog No. M19979 CAS No. 16564-43-5
Glycochenodeoxycholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 100MG | 38 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGlycochenodeoxycholic acid sodium salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlycochenodeoxycholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment.
-
DescriptionGlycochenodeoxycholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment.
-
In Vitro——
-
In Vivo——
-
SynonymsGCDCA | Sodium glycochenodeoxycholate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number16564-43-5
-
Formula Weight471.61
-
Molecular FormulaC26H42NNaO5
-
Purity>98% (HPLC)
-
SolubilityDMSO:200 mM
-
SMILES[Na+].C[C@H](CCC(=O)NCC([O-])=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Utanohara S et al. The effect of ursodeoxycholic acid on glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes. Toxicology. 2005 Oct 15;214(1-2):77-86.
molnova catalog
related products
-
Suc-LEPF-pNA
Suc-LEPF-pNA
-
Trametenolic acid
Trametenolic acid is a cytotoxic agent.It exhibits a mode of mixed inhibition with a K I of 0.9μM, K IS of 0.5μM, and an IC50 of 7.25μM.
-
Orexin A (human, rat...
Endogenous agonist at orexin receptors (Ki values are 20 and 38 nM for OX1 and OX2 receptors respectively). Stimulates feeding following central administration and may be involved in the control of sleep-wake cycle and other hypothalamic functions.
